Vencio Eneida F, Jenkins Robert B, Schiller Jamie L, Huynh Tuong Vy T, Wenger Doris D, Inwards Carrie Y, Oliveira Andre M
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA.
Am J Surg Pathol. 2007 Feb;31(2):319-21. doi: 10.1097/01.pas.0000213366.33627.a0.
Erdheim-Chester disease (ECD) is a rare histiocytic disorder of unknown etiology that involves predominantly bone and viscera. Whether ECD represents a reactive or neoplastic process has been debated since its initial description. Herein, we report for the first time the cytogenetic findings of a case of ECD diagnosed at Mayo Clinic Rochester. The tumor occurred in the right tibia of a 35-year-old man and showed the balanced chromosomal translocation t(12;15;20)(q11;q24;p13.3), among other numeric chromosomal abnormalities. The lesion was positive for CD68 and negative for CD1a and S100. These findings support the idea that some cases of ECD are clonal neoplastic disorders of putative histiocytic differentiation. However, additional studies are warranted to confirm whether the chromosomal abnormalities found in this case represent recurrent cytogenetic events.
厄尔德海姆-切斯特病(ECD)是一种病因不明的罕见组织细胞疾病,主要累及骨骼和内脏。自首次描述以来,ECD是反应性还是肿瘤性过程一直存在争议。在此,我们首次报告了在罗切斯特梅奥诊所诊断的一例ECD的细胞遗传学结果。肿瘤发生在一名35岁男性的右胫骨,除其他染色体数目异常外,还显示出平衡的染色体易位t(12;15;20)(q11;q24;p13.3)。病变CD68呈阳性,CD1a和S100呈阴性。这些发现支持了一些ECD病例是假定组织细胞分化的克隆性肿瘤性疾病的观点。然而,需要进一步研究以确认该病例中发现的染色体异常是否代表复发性细胞遗传学事件。